# Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

> **NCT06375499** · NA · COMPLETED · sponsor: **Laboratoires Thea** · enrollment: 74 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DEVICE:** T2769
- **DEVICE:** Hylo-Forte®

## Key facts

- **NCT ID:** NCT06375499
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-17
- **Primary completion:** 2025-01-06
- **Final completion:** 2025-01-06
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06375499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06375499, "Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06375499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*